Thu, Mar 5, 2015, 6:40 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Affymax, Inc. (AFFY) Message Board

  • khcdot2 khcdot2 Jul 17, 2013 10:46 AM Flag

    Hey Maxdad, Jagan

    Thanks for all of your input on the board.

    I haven't seen much discussion on O's other indications. Aren't there still 2 trials ongoing? Could you please weigh in on what these other indications might be worth to AFFY.


    Sentiment: Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • curtis238 Jul 17, 2013 11:46 AM Flag

      I believe there are no ongoing trials of omontys. They recalled it and are figuring out what went wrong. I also believe they figured it out and are closing all other doors until affy is able to put it back on the market. But what maxdad said, is correct from what I've read

      Sentiment: Strong Buy

    • As far as I know there were only two original indications for Omontys. With and without dialysis. And then two forms of administering Omontys. Intravenous and sub-cutaneous. Without dialysis did not have great results like with dialysis AND sub-cutaneous injections had no significant problems.

      FWIW, someone on the Questcor YMB said that Takeda has started up manufacturing of Omontys again per the FDA. I have NO corroborating information on this, so please take it with a grain of salt.

0.135-0.0100(-6.90%)Mar 5 3:52 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.